ArticleClinical drug investigation2022

The Costs and Health Benefits of Expanded Access to MDMA-assisted Therapy for Chronic and Severe PTSD in the USA: A Modeling Study.

Anton L V Avanceña et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.